Search - tctmd.com

Displaying 1 - 20 of 43

Sort: Relevancy | Date

Presentation PCI Outcomes 2014

The Thoughtful Approach to Recurrent DES Restenosis

Presenter: Robert A. Byrne

March 28, 2014

Presentation PCI Outcomes 2014

Primary PCI in STEMI: The Controversy of Culprit Only vs Immediate vs Delayed Revascularization

Presenter: Stephan Windecker

March 28, 2014

Presentation PCI Outcomes 2014

Physiology and/or Imaging Guided PCR: A Bordeline Vascular Personality

Presenter: David Erlinge

March 28, 2014

Presentation PCI Outcomes 2014

Perspectives on PCI vs CABG in the Diabetic Patient: The FREEDOM to Disagree with FREEDOM

Presenter: Gregg W. Stone

March 28, 2014

Presentation PCI Outcomes 2014

PCI vs. Optimal Medical Therapy in Stable Ischemic Heart Disease: Has the Last Year Brought More Clarity or Confusion?

Presenter: Ajay J. Kirtane

March 28, 2014

Presentation PCI Outcomes 2014

PCI vs. CABG in a Diabetic Patient: A Case Study

Presenter: Thomas D. Stuckey

March 28, 2014

Presentation PCI Outcomes 2014

Optimizing PCI with Physiology: Rationale and Case Examples

Presenter: Allen Jeremias

March 28, 2014

Presentation PCI Outcomes 2014

Optimizing PCI with IVUS and OCT: Rationale and Case Examples

Presenter: Akiko Maehara

March 28, 2014

Presentation PCI Outcomes 2014

Left Main Percutaneous Revascularization: Perspectives on Advances in Method, Outcome and Clinical Decision Making

Presenter: David E. Kandzari

March 28, 2014

Presentation PCI Outcomes 2014

Case Study 3: PCI vs CABG For Left Main CAD

Presenter: Davide Capodanno

March 28, 2014

Presentation PCI Outcomes 2014

Case Study 1: PCI vs. Optimal Medical Therapy in Stable CAD

Presenter: Sripal Bangalore

March 28, 2014

Presentation PCI Outcomes 2014

BMS, DES, and BRS: A “Rational”Approach for Stent Selection

Presenter: Tullio Palmerini

March 28, 2014

Presentation PCI Outcomes 2014

Atrial Fibrillation and PCI: Antiplatelet Therapy Recommendations

Presenter: Christopher Granger

March 28, 2014

Presentation PCI Outcomes 2014

Antiplatelet Therapy Before, During, and After PCI: Which One and How Long?

Presenter: Dominick J. Angiolillo

March 28, 2014

Presentation PCI Outcomes 2013

Updates and Revascularization Decisions - Case 1: PCI vs Medical Therapy in Stable Coronary Artery Disease

Presenter: Manish A. Parikh

March 07, 2013

Presentation PCI Outcomes 2013

Strengths, Limitations and Real-world Implications of Appropriateness Use Criteria

Presenter: Dennis T. Ko

March 07, 2013

Presentation PCI Outcomes 2013

Perspectives on the Selection and Duration of Dual Antiplatelet Therapy

Presenter: Dominick J. Angiolillo

March 07, 2013

Presentation PCI Outcomes 2013

Perspectives on PCI vs. Medical Therapy in Stable Coronary Artery Disease

Presenter: Gregg W. Stone

March 07, 2013

Presentation PCI Outcomes 2013

Perspectives on PCI and CABG for Multivessel Disease

Presenter: Ajay J. Kirtane

March 07, 2013

Presentation PCI Outcomes 2013

Optimizing PCI Outcomes: FFR meets PET

Presenter: Nils P. Johnson

March 07, 2013

Advertisement

The Thoughtful Approach to Recurrent DES Restenosis

Primary PCI in STEMI: The Controversy of Culprit Only vs Immediate vs Delayed Revascularization

Physiology and/or Imaging Guided PCR: A Bordeline Vascular Personality

Perspectives on PCI vs CABG in the Diabetic Patient: The FREEDOM to Disagree with FREEDOM

PCI vs. Optimal Medical Therapy in Stable Ischemic Heart Disease: Has the Last Year Brought More Clarity or Confusion?

PCI vs. CABG in a Diabetic Patient: A Case Study

Optimizing PCI with Physiology: Rationale and Case Examples

Optimizing PCI with IVUS and OCT: Rationale and Case Examples

Left Main Percutaneous Revascularization: Perspectives on Advances in Method, Outcome and Clinical Decision Making

Case Study 3: PCI vs CABG For Left Main CAD

Case Study 1: PCI vs. Optimal Medical Therapy in Stable CAD

BMS, DES, and BRS: A “Rational”Approach for Stent Selection

Atrial Fibrillation and PCI: Antiplatelet Therapy Recommendations

Antiplatelet Therapy Before, During, and After PCI: Which One and How Long?

Updates and Revascularization Decisions - Case 1: PCI vs Medical Therapy in Stable Coronary Artery Disease

Strengths, Limitations and Real-world Implications of Appropriateness Use Criteria

Perspectives on the Selection and Duration of Dual Antiplatelet Therapy

Perspectives on PCI vs. Medical Therapy in Stable Coronary Artery Disease

Perspectives on PCI and CABG for Multivessel Disease

Optimizing PCI Outcomes: FFR meets PET

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content